MAOB and central nervous system cancer: In the context of a previously described increase of MAO-B activity in human gliomas versus non-tumoral tissues [108], Sharpe et al. demonstrated that MAO-B registers a more than fourfold upregulation in glioma cells, an observation which the authors exploited to develop MP-MUS, a novel prodrug selectively activated by MAO-B.